Cancer Treatment Market Research Reports & Industry Analysis

Worldwide cancer affects more than 10 million people each year and the incidence of cancer is expected to increase by 2.4% annually to reach 14 million per year by 2020. Cancer is the second most common death in the industrialized world.

Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.

With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.

...Show More ...Show Less


Cancer Treatment Industry Research & Market Reports

  • The 2025-2030 World Outlook for Cancer Testing-Screening

    ... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More

  • The 2025-2030 World Outlook for Cancer Therapeutics

    ... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More

  • The 2025-2030 World Outlook for Cancer-Treating Drugs

    ... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More

  • The 2025-2030 World Outlook for Pancreatic Cancer Drugs

    ... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to ... Read More

  • The 2025-2030 World Outlook for Liver Cancer Diagnostics

    ... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to ... Read More

  • The 2025-2030 World Outlook for Liver Cancer Drugs

    ... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to ... Read More

  • The 2025-2030 World Outlook for Microwave Ablations

    ... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More

  • The 2025-2030 World Outlook for Breast Cancer Diagnostics and Drug Technologies

    ... are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These ... Read More

  • The 2025-2030 World Outlook for Granulocyte Colony Stimulating Factor (G-CSF) Cancer Supportive Care

    ... each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and ... Read More

  • The 2025-2030 World Outlook for Progestogens for Cancer Cachexia

    ... latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the ... Read More

  • The 2025-2030 World Outlook for Breast Cancer Liquid Biopsies

    ... latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the ... Read More

  • The 2025-2030 World Outlook for Breast Cancer Drugs

    ... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to ... Read More

  • The 2025-2030 World Outlook for Ovarian Cancer Drugs and Diagnostics

    ... for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks ... Read More

  • The 2025-2030 World Outlook for Ovarian Cancer Diagnostics

    ... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to ... Read More

  • The 2025-2030 World Outlook for Ovarian Cancer Drugs

    ... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to ... Read More

  • The 2025-2030 World Outlook for Ovarian Cancer Therapeutics

    ... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to ... Read More

  • The 2025-2030 World Outlook for Melanoma Scanners

    ... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More

  • The 2025-2030 World Outlook for Uterine Cancer Therapeutics and Diagnostics

    ... for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks ... Read More

  • The 2025-2030 World Outlook for Uterine Cancer Treatments and Diagnostics

    ... for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks ... Read More

  • The 2025-2030 World Outlook for Uterine Sarcoma Therapeutics and Diagnostics

    ... for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks ... Read More

  • The 2025-2030 World Outlook for Endocrine Pancreatic Cancer Drugs

    ... latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the ... Read More

  • The 2025-2030 World Outlook for Angiogenesis Inhibitors and Stimulators

    ... latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the ... Read More

  • The 2025-2030 World Outlook for Melanoma Therapeutics

    ... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More

  • The 2025-2030 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb)

    ... for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks ... Read More

  • The 2025-2030 World Outlook for Gastric Cancer Drugs

    ... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings